Form 4: Evolent Health Director Russell Monroe Glass Reports Changes in Beneficial Ownership

Director Russell Monroe Glass reports acquisition of restricted stock units and changes in Class A Common Stock holdings.

Summary

• Russell Monroe Glass, a director of Evolent Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On June 6, 2024, Glass acquired 7,709 shares of Class A Common Stock as restricted stock units.
• These restricted stock units vest on the earlier of June 6, 2025, or the date of the company's 2025 annual meeting, contingent upon continued service.
• Glass also reported a decrease of 6,046 shares of Class A Common Stock held indirectly through a trust.
• Following these transactions, Glass directly owns 8,872 shares of Class A Common Stock and continues to have indirect ownership through a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating changes in ownership, with no inherently positive or negative implications.

Positives

• The acquisition of restricted stock units aligns the director's interests with the company's long-term performance.

Negatives

• The decrease in indirectly held shares could be interpreted in various ways, but without further context, it's difficult to assess the specific reason or impact.

Risks

• The vesting of the restricted stock units is contingent upon continued service, creating a potential risk if the director were to leave the company before the vesting date.

Future Outlook

The director's future holdings will depend on vesting of restricted stock units and any further transactions.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in the director's holdings of Evolent Health stock.

Stakeholder Impact

• Shareholders may be interested in tracking insider transactions as an indicator of management's confidence in the company.

Key Dates